Brian J. North is an Assistant Professor in the Biomedical Sciences Department. After receiving his B.A. from Gustavus Adolphus College, he completed his Ph.D. from the University of California San Francisco with Dr. Eric Verdin. He then went on to his postdoctoral fellowship at Harvard Medical School with Dr. David Sinclair, and subsequently was a Research Assistant Professor at Beth Israel Deaconess Medical Center where he worked closely with the lab of Dr. Wenyi Wei. His main research focus is to understand the molecular and cellular pathways involved in regulating the process of aging, and how changes in these pathways contribute to the development of age-related diseases, with a primary interest in tumorigenesis.
The North lab studies the interrelationship between aging and cancer. We are particularly interested in the the role of the ubiquitin-proteasome system in targeting tumor suppressors and oncogenes in an age-dependent manner.
Cancer Research Area(s)
Colon Cancer
Skin Cancer
Age Related Cancer Mechanisms
Research Focus
Molecular basis for aging and its impact on age-related disease susceptibility; Understanding the roles of E3 ubiquitin ligases in tumorigenesis; Regulation and function of NAD+-dependent deacetylases
Pun Renju, Abstract P2037: Bubr1 Is A Critical Regulator Of Cardiac Aging 2023
Pun Renju, Abstract P1068: BubR1 Is A Novel Regulator Of Cardiac Development And Conduction 2022
Publications
Seminars in cancer biology Pun Renju, BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer 106-107, p. 201 - 216 2024
Kim Michael, Abstract P1169: BubR1 Regulates Cardiac Development Through CamkII In Vivo 2023
Cellular oncology (Dordrecht) Zou Qiang, E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities 2023
Frontiers in cardiovascular medicine Pun Renju, Role of Connexin 43 phosphorylation on Serine-368 by PKC in cardiac function and disease 9, p. 1080131 - 1080131 2023
Dai Xiangpeng, Editorial 2022
Cell and Bioscience Bloom Celia R., Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1 11:1 2021
Nature Communications Liu Jing, Genetic fusions favor tumorigenesis through degron loss in oncogenes 12:1 2021
Cell Reports Shimizu Kouhei, Interplay between protein acetylation and ubiquitination controls MCL1 protein stability 37:6 2021
Molecular biology reports Ma Ying, Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation 48:9, p. 6589 - 6601 2021
Mediators of Inflammation Kumari Niti, Unraveling the Molecular Nexus between GPCRs, ERS, and EMT 2021 2021
Nature Cell Biology Gao Yang, Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy 22:9, p. 1064 - 1075 2020
Biochimica et Biophysica Acta - Reviews on Cancer Cheng Ji, Functional analysis of deubiquitylating enzymes in tumorigenesis and development 1872:2 2019
Molecular Oncology Ma Ying, SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation 13:2, p. 307 - 321 2019
Biochimica et Biophysica Acta - Reviews on Cancer Cheng Ji, The emerging role for Cullin 4 family of E3 ligases in tumorigenesis 1871:1, p. 138 - 159 2019
Protein and Cell Ci Yanpeng, SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation 9:10, p. 879 - 889 2018
Biochimica et Biophysica Acta - Reviews on Cancer Cheng Ji, Functional analysis of Cullin 3 E3 ligases in tumorigenesis 1869:1, p. 11 - 28 2018
Nature Wang Bin, TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling 545:7654, p. 365 - 369 2017
PloS one North Brian J., Enhancement of pomalidomide anti-Tumor response with ACY-241, a selective HDAC6 inhibitor 12:3 2017
Science Signaling Nihira Naoe T., Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function 10:466 2017
Science Signaling Shimizu Kouhei, The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis 10:460 2017
Oncotarget Tan Yuyong, Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6 8:29, p. 47890 - 47901 2017
Oncotarget Li Xiaoning, Smurf1 regulation of DAB2IP controls cell proliferation and migration 7:18, p. 26057 - 26069 2016
Nature Communications Rumpf Tobias, Selective Sirt2 inhibition by ligand-induced rearrangement of the active site 6 2015
EMBO Journal North Brian J., SIRT2 induces the checkpoint kinase BubR1 to increase lifespan 33:13, p. 1438 - 1453 2014
Oncotarget Wu Xiaomian, SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination 5:12, p. 4211 - 4221 2014
Oncotarget Dai Xiangping, Negative regulation of DAB2IP by Akt and SCFFbw7 pathways 5:10, p. 3307 - 3315 2014
Neoplasia Bonezzi Katiuscia, Inhibition of SIRT2 potentiates the anti-motility activity of taxanes 14:9, p. 846 - 854 2012
Cell Metabolism Price Nathan L., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function 15:5, p. 675 - 690 2012
Circulation Research North Brian J., The intersection between aging and cardiovascular disease 110:8, p. 1097 - 1108 2012
Proceedings of the National Academy of Sciences of the United States of America Beirowski Bogdan, Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling 108:43, p. E952 - E961 2011
Journal of Biological Chemistry Ahuja Nidhi, Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase 282:46, p. 33583 - 33592 2007
PloS one North Brian J., Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis 2:8 2007
Journal of Biological Chemistry North Brian J., Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation 282:27, p. 19546 - 19555 2007
Trends in Biochemical Sciences North Brian J., Sirtuins 32:1, p. 1 - 4 2007
Methods North Brian J., Preparation of enzymatically active recombinant class III protein deacetylases 36:4, p. 338 - 345 2005
FASEB Journal Waltregny David, Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle cell contractility 19:8, p. 966 - 968 2005
PLoS Biology Pagans Sara, SIRT1 regulates HIV transcription via Tat deacetylation 3:2, p. 210 - 220 2005
American Journal of Pathology Waltregny David, Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues 165:2, p. 553 - 564 2004
European Journal of Histochemistry Waltregny D., Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells 48:3, p. 273 - 290 2004
Genome Biology North Brian J., Sirtuins 5:5 2004
Molecular Cell North Brian J., The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase 11:2, p. 437 - 444 2003
Methods in Enzymology Verdin Eric, Measurement of Mammalian Histone Deacetylase Activity 377, p. 180 - 196 2003
Journal of Cell Biology Schwer Björn, The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase 158:4, p. 647 - 657 2002
Developmental Biology Verzi Michael P., N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor 249:1, p. 174 - 190 2002
National Institutes of Health K01 Career Development Award National Institutes of Health K01 Career Development Award (NIH/NIA AG052627)
Gustavus Adolphus College Decade Award Gustavus Adolphus College Decade Award
BIDMC/National Institutes of Aging T32 Translational Research in Aging Award BIDMC/National Institutes of Aging T32 Translational Research in Aging Award